Skip to main content
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases 12/2017

25.07.2017 | Original Article

Reproducible measurement of vancomycin MICs within the susceptible range in Staphylococcus aureus by a broth microdilution method with a “quasi-continuum” gradient of antibiotic concentrations

verfasst von: R. Falcón, E. M. Mateo, A. Talaya, E. Giménez, V. Vinuesa, M. Á. Clari, D. Navarro

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 12/2017

Einloggen, um Zugang zu erhalten

Abstract

The availability of reproducible broth microdilution (BMD) methods including inter log2 antibiotic dilutions for measuring Staphylococcus aureus (SA) vancomycin minimum inhibitory concentrations (MICs) within the susceptible range is needed to elucidate the impact of vancomycin MICs on clinical outcomes of invasive SA infections. Here, we report on the development of a very precise BMD method that incorporates the following incremental antibiotic concentrations: 0.50, 0.62, 0.75, 0.87, 1.0, 1.25, 1.40, 1.50, 1.60, 1.75, and 2.0 μg/mL. The intra- and inter-assay coefficients of variation of this method were around 20%. The mean of the differences in MIC values for all isolates obtained across two independent runs performed at one center was 0.04 μg/mL [95% confidence interval (CI), 0.011–0.07 μg/mL] and that for ten isolates measured at two different centers was 0.04 μg/mL (95% CI, 0–13 μg/mL). Vancomycin MIC values differed by less than 0.1 μg/mL between runs for most isolates. Storage of isolates at −20 °C for up to 3 months had no impact on the vancomycin MIC values. The mean vancomycin MIC values obtained by the Etest using a standard inoculum (0.5 McFarland) were significantly higher (p ≤ 0.001) than those measured by BMD and the MIC values measured by the two methods correlated poorly (Rho, 0.319; p = 0.148). Nevertheless, the mean MIC values measured by the Etest using lower inocula (107 or 106 CFU/mL) and those measured by BMD were comparable and correlated significantly (p = 0.004 for 107 CFU/mL and p = 0.029 for 106 CFU/mL).
Literatur
1.
Zurück zum Zitat Rodríguez-Créixems M, Alcalá L, Muñoz P, Cercenado E, Vicente T, Bouza E (2008) Bloodstream infections: evolution and trends in the microbiology workload, incidence, and etiology, 1985–2006. Medicine (Baltimore) 87:234–249CrossRef Rodríguez-Créixems M, Alcalá L, Muñoz P, Cercenado E, Vicente T, Bouza E (2008) Bloodstream infections: evolution and trends in the microbiology workload, incidence, and etiology, 1985–2006. Medicine (Baltimore) 87:234–249CrossRef
2.
Zurück zum Zitat van Hal SJ, Lodise TP, Paterson DL (2012) The clinical significance of vancomycin minimum inhibitory concentration in Staphylococcus aureus infections: a systematic review and meta-analysis. Clin Infect Dis 54:755–771CrossRefPubMed van Hal SJ, Lodise TP, Paterson DL (2012) The clinical significance of vancomycin minimum inhibitory concentration in Staphylococcus aureus infections: a systematic review and meta-analysis. Clin Infect Dis 54:755–771CrossRefPubMed
3.
Zurück zum Zitat Jacob JT, DiazGranados CA (2013) High vancomycin minimum inhibitory concentration and clinical outcomes in adults with methicillin-resistant Staphylococcus aureus infections: a meta-analysis. Int J Infect Dis 17:e93–e100CrossRefPubMed Jacob JT, DiazGranados CA (2013) High vancomycin minimum inhibitory concentration and clinical outcomes in adults with methicillin-resistant Staphylococcus aureus infections: a meta-analysis. Int J Infect Dis 17:e93–e100CrossRefPubMed
4.
Zurück zum Zitat Kalil AC, Van Schooneveld TC, Fey PD, Rupp ME (2014) Association between vancomycin minimum inhibitory concentration and mortality among patients with Staphylococcus aureus bloodstream infections: a systematic review and meta-analysis. JAMA 312:1552–1564CrossRefPubMed Kalil AC, Van Schooneveld TC, Fey PD, Rupp ME (2014) Association between vancomycin minimum inhibitory concentration and mortality among patients with Staphylococcus aureus bloodstream infections: a systematic review and meta-analysis. JAMA 312:1552–1564CrossRefPubMed
5.
Zurück zum Zitat Falcón R, Madrid S, Tormo N, Casañ C, Albert E, Gimeno C, Navarro D (2015) Intra- and interinstitutional evaluation of an Etest for vancomycin minimum inhibitory concentration measurement in Staphylococcus aureus blood isolates. Clin Infect Dis 61:1490–1492CrossRefPubMed Falcón R, Madrid S, Tormo N, Casañ C, Albert E, Gimeno C, Navarro D (2015) Intra- and interinstitutional evaluation of an Etest for vancomycin minimum inhibitory concentration measurement in Staphylococcus aureus blood isolates. Clin Infect Dis 61:1490–1492CrossRefPubMed
6.
Zurück zum Zitat Kruzel MC, Lewis CT, Welsh KJ, Lewis EM, Dundas NE, Mohr JF, Armitige LY, Wanger A (2011) Determination of vancomycin and daptomycin MICs by different testing methods for methicillin-resistant Staphylococcus aureus. J Clin Microbiol 49:2272–2273CrossRefPubMedPubMedCentral Kruzel MC, Lewis CT, Welsh KJ, Lewis EM, Dundas NE, Mohr JF, Armitige LY, Wanger A (2011) Determination of vancomycin and daptomycin MICs by different testing methods for methicillin-resistant Staphylococcus aureus. J Clin Microbiol 49:2272–2273CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Muñoz-Cobo B, Sancho-Tello S, Costa E, Bravo D, Torregrosa I, de Lomas JG, Navarro D (2011) Differences in vancomycin minimum inhibitory concentrations for Staphylococcus aureus obtained with the automated Phoenix™ system, the Clinical and Laboratory Standards Institute broth microdilution method and the standard Etest. Int J Antimicrob Agents 37:278–279CrossRefPubMed Muñoz-Cobo B, Sancho-Tello S, Costa E, Bravo D, Torregrosa I, de Lomas JG, Navarro D (2011) Differences in vancomycin minimum inhibitory concentrations for Staphylococcus aureus obtained with the automated Phoenix™ system, the Clinical and Laboratory Standards Institute broth microdilution method and the standard Etest. Int J Antimicrob Agents 37:278–279CrossRefPubMed
8.
Zurück zum Zitat Charlton CL, Hindler JA, Turnidge J, Humphries RM (2014) Precision of vancomycin and daptomycin MICs for methicillin-resistant Staphylococcus aureus and effect of subculture and storage. J Clin Microbiol 52:3898–3905CrossRefPubMedPubMedCentral Charlton CL, Hindler JA, Turnidge J, Humphries RM (2014) Precision of vancomycin and daptomycin MICs for methicillin-resistant Staphylococcus aureus and effect of subculture and storage. J Clin Microbiol 52:3898–3905CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Falcón R, Martínez A, Albert E, Madrid S, Oltra R, Giménez E, Soriano M, Vinuesa V, Gozalbo D, Gil ML, Navarro D (2016) High vancomycin MICs within the susceptible range in Staphylococcus aureus bacteraemia isolates are associated with increased cell wall thickness and reduced intracellular killing by human phagocytes. Int J Antimicrob Agents 47:343–350CrossRefPubMed Falcón R, Martínez A, Albert E, Madrid S, Oltra R, Giménez E, Soriano M, Vinuesa V, Gozalbo D, Gil ML, Navarro D (2016) High vancomycin MICs within the susceptible range in Staphylococcus aureus bacteraemia isolates are associated with increased cell wall thickness and reduced intracellular killing by human phagocytes. Int J Antimicrob Agents 47:343–350CrossRefPubMed
10.
Zurück zum Zitat Clinical and Laboratory Standards Institute (CLSI) (2012) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; Approved standard—Ninth edition. CLSI document M07-A9. CLSI, Wayne Clinical and Laboratory Standards Institute (CLSI) (2012) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; Approved standard—Ninth edition. CLSI document M07-A9. CLSI, Wayne
11.
Zurück zum Zitat Clinical and Laboratory Standards Institute (CLSI) (2014) Performance standards for antimicrobial susceptibility testing; Twenty-fourth informational supplement. CLSI document M100-S24. CLSI, Wayne Clinical and Laboratory Standards Institute (CLSI) (2014) Performance standards for antimicrobial susceptibility testing; Twenty-fourth informational supplement. CLSI document M100-S24. CLSI, Wayne
12.
Zurück zum Zitat Ludwig F, Edwards B, Lawes T, Gould IM (2012) Effects of storage on vancomycin and daptomycin MIC in susceptible blood isolates of methicillin-resistant Staphylococcus aureus. J Clin Microbiol 50:3383–3387CrossRefPubMedPubMedCentral Ludwig F, Edwards B, Lawes T, Gould IM (2012) Effects of storage on vancomycin and daptomycin MIC in susceptible blood isolates of methicillin-resistant Staphylococcus aureus. J Clin Microbiol 50:3383–3387CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Shoji H, Maeda M, Shirakura T, Takuma T, Ugajin K, Fukuchi K, Ishino K, Niki Y (2015) More accurate measurement of vancomycin minimum inhibitory concentration indicates poor outcomes in meticillin-resistant Staphylococcus aureus bacteraemia. Int J Antimicrob Agents 46:532–537CrossRefPubMed Shoji H, Maeda M, Shirakura T, Takuma T, Ugajin K, Fukuchi K, Ishino K, Niki Y (2015) More accurate measurement of vancomycin minimum inhibitory concentration indicates poor outcomes in meticillin-resistant Staphylococcus aureus bacteraemia. Int J Antimicrob Agents 46:532–537CrossRefPubMed
14.
Zurück zum Zitat Hos NJ, Jazmati N, Stefanik D, Hellmich M, AlSael H, Kern WV, Rieg S, Wisplinghoff H, Seifert H, Kaasch AJ (2017) Determining vancomycin Etest MICs in patients with MRSA bloodstream infection does not support switching antimicrobials. J Infect 74:248–259CrossRefPubMed Hos NJ, Jazmati N, Stefanik D, Hellmich M, AlSael H, Kern WV, Rieg S, Wisplinghoff H, Seifert H, Kaasch AJ (2017) Determining vancomycin Etest MICs in patients with MRSA bloodstream infection does not support switching antimicrobials. J Infect 74:248–259CrossRefPubMed
15.
Zurück zum Zitat Reed GF, Lynn F, Meade BD (2002) Use of coefficient of variation in assessing variability of quantitative assays. Clin Diagn Lab Immunol 9:1235–1239PubMedPubMedCentral Reed GF, Lynn F, Meade BD (2002) Use of coefficient of variation in assessing variability of quantitative assays. Clin Diagn Lab Immunol 9:1235–1239PubMedPubMedCentral
16.
Zurück zum Zitat Rybak MJ, Vidaillac C, Sader HS, Rhomberg PR, Salimnia H, Briski LE, Wanger A, Jones RN (2013) Evaluation of vancomycin susceptibility testing for methicillin-resistant Staphylococcus aureus: comparison of Etest and three automated testing methods. J Clin Microbiol 51:2077–2081CrossRefPubMedPubMedCentral Rybak MJ, Vidaillac C, Sader HS, Rhomberg PR, Salimnia H, Briski LE, Wanger A, Jones RN (2013) Evaluation of vancomycin susceptibility testing for methicillin-resistant Staphylococcus aureus: comparison of Etest and three automated testing methods. J Clin Microbiol 51:2077–2081CrossRefPubMedPubMedCentral
Metadaten
Titel
Reproducible measurement of vancomycin MICs within the susceptible range in Staphylococcus aureus by a broth microdilution method with a “quasi-continuum” gradient of antibiotic concentrations
verfasst von
R. Falcón
E. M. Mateo
A. Talaya
E. Giménez
V. Vinuesa
M. Á. Clari
D. Navarro
Publikationsdatum
25.07.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 12/2017
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-017-3067-8

Weitere Artikel der Ausgabe 12/2017

European Journal of Clinical Microbiology & Infectious Diseases 12/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.